Startups
Edit
RetroSense Therapeutics
http://www.retro-sense.com/Last activity: 13.11.2015
Active - Reference to HugeDomains
Overview
Employees
201-500
Total raised
$12M
Founded date
2009
Funding Rounds 2
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Jan 9, 2015 | Series A round | $6M |
Mentions in press and media 8
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 12, 2015 | RetroSense Therapeutics Secures $6M in Series B Financing | RetroSense Therapeutics, an Ann Arbor, MI-based clinical-stage biopharmaceutical company, secured $6m in Series B financing. Backers included The existing investors BlueWater Angels, and new investors RBV Capital, ExSight Capital, and Sante... |
| Nov 12, 2015 | Restoring vision with gene therapy: RetroSense gets $6M | Funding for this round came from existing angels, including BlueWater Angels, but also from RBV Capital, ExSight Capital and Santen Pharmaceutical. Santen Pharmaceutical, based in Japan, has been developing therapies for vision disorders fo... |
| Jan 12, 2015 | RetroSense Therapeutics Raises $6M in Series A | ANN ARBOR, MI, Privately-held biopharmaceutical company, today announced that it has secured $6 million in a Series A financing. >> Click here for more funding data on RetroSense Therapeutics >> To export RetroSense Therapeu... |
| Jan 9, 2015 | RetroSense Therapeutics Secures $6M in Series A Financing | RetroSense Therapeutics, a Ann Arbor, MI-based biopharmaceutical company developing life-enhancing gene therapies, secured $6m in Series A financing. Backers included Nerveda, Blue Water Angels, SDL Ventures, Tech Coast Angels, and Michigan... |
| Oct 12, 2011 | Retinal degeneration treatment firm raising funds ahead of clinical trials | In retinal degenerative diseases, the loss of photoreceptors, which convert light to nerve impulses and send them to the brain, leads to progressive peripheral vision loss and night vision troubles in patients. RetroSense’s lead candidate, ... |
| Restoring vision with gene therapy: RetroSense gets $6M | An Ann Arbor optogenetics startup just raised capital to fuel clinical research for its gene therapy that could help restore vision. RetroSense Therapeutics just closed out a $6 million Series B round to help the company complete a Phase 1/... | |
| Retinal degeneration treatment firm raising funds ahead of clinical trials | A Michigan company developing a treatment to help restore vision in patients with retinal degeneration hopes to have its lead candidate in clinical trials in 2012. RetroSense Therapeutics, an Ann Arbor startup company, is targeting patients... |
Reviews 0
FAQ about RetroSense Therapeutics
When was RetroSense Therapeutics founded?
RetroSense Therapeutics was founded in 2009.
How much funding has RetroSense Therapeutics raised?
RetroSense Therapeutics has raised $12M in total across 2 funding rounds.
What funding rounds has RetroSense Therapeutics raised?
Parsers VC lists 2 funding rounds of RetroSense Therapeutics, among them a Series A round of $6M on Jan 9, 2015.
What has the press written about RetroSense Therapeutics?
Parsers VC has collected 8 articles mentioning RetroSense Therapeutics, among them “RetroSense Therapeutics Secures $6M in Series B Financing” (Nov 12, 2015) and “Restoring vision with gene therapy: RetroSense gets $6M” (Nov 12, 2015).
Is RetroSense Therapeutics still active?
Yes, RetroSense Therapeutics is active; its latest activity on Parsers VC dates from Nov 13, 2015.